
Sharon Marie Castellino MD MSc
Pediatric Hematologic Oncology
Professor of Pediatrics, Emory University School of Medicine Director, Leukemia/Lymphoma Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta
Join to View Full Profile
- 5461 Meridian Mark RdSte 400Atlanta, GA 30342 
- Phone+1 404-785-1112 
- Fax+1 404-785-3600 
Dr. Castellino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
 Wake Forest UniversityMSc, Health Outcomes, 2005 - 2008 Wake Forest UniversityMSc, Health Outcomes, 2005 - 2008
 Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1995 - 1998 Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1995 - 1998
 Duke University HospitalResidency, Pediatrics, 1994 - 1995 Duke University HospitalResidency, Pediatrics, 1994 - 1995
 Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1992 - 1994 Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1992 - 1994
 Duke University School of MedicineClass of 1992 Duke University School of MedicineClass of 1992
 Mount Holyoke CollegeBA, Biochemistry, Magna Cum Laude, 1984 - 1988 Mount Holyoke CollegeBA, Biochemistry, Magna Cum Laude, 1984 - 1988
Certifications & Licensure
 GA State Medical License 2015 - 2026 GA State Medical License 2015 - 2026
 NC State Medical License 1994 - 2026 NC State Medical License 1994 - 2026
 TN State Medical License 1998 - 2005 TN State Medical License 1998 - 2005
 American Board of Pediatrics Pediatric Hematology-Oncology American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Clinician Investigator Award Wake Forest School of Medicine, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Start of enrollment: 2008 Jul 17
- Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.Bradford S Hoppe, Raymond B Mailhot-Vega, Lindsay A Renfro, Qinglin Pei, Anne-Marie Charpentier
 International Journal of Radiation Oncology, Biology, Physics. 2025-11-15
- Changes in Medicaid Enrollment Among Adult Survivors of Childhood Cancer After Medicaid Expansion: A Report From the Childhood Cancer Survivor Study.Xu Ji, Xin Hu, Paul C Nathan, Wendy M Leisenring, Gregory T Armstrong
 JCO Oncology Practice. 2025-10-17
- Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors.Xu Ji, Rebecca S Williamson Lewis, Karen Wasilewski-Masker, Karen E Effinger, Kevin C Ward
 Journal of the National Cancer Institute. 2025-09-26
Journal Articles
- Incidence and Outcomes of Lymphoid Malignancies in Adolescent and Young Adult Patients in the United StatesSharon Castellino, Frank G Keller, Christopher R Flowers, British Journal of Haematology
- Occult GI Bleeding in a 1 yo Pediatric Cancer SurvivorGrimes K, Kratzer T, Russo K, Bourland D, Castellino SM, J Pediatr Gastroenerol Nutr., 1/1/2014
- Hepato-Biliary Late Effects in Survivors of Childhood and Adolescent Cancer - A Report from the Children’s Oncology GroupCastellino SM, Muir A, Shah A, Shope S, McMullen K, Ruble K, Barber A, Davidoff A, Hudson MM, Pediatr Blood Cancer, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Intensive therapy free survival (ITFS) for early-stage Hodgkin lymphoma (cHL) including chemotherapy and radiation therapy (IFRT) for recurrence after chemotherapy al...Keller F, Castellino SM et al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
- Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study.Effinger K, Leisenring W, Oeffinger KC, Hudson MM, Ness KK, Marina N, Castellino SM Stovall M, Armstrong GT, Robison LL, Sainani K, Whittemore AS, International Symposium Pediatric HL, Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
- Outcomes and Patterns of Failure in Children/Adolescents with low risk Hodgkin Lymphoma (HL) who are FDG-PET (PET3) positive after AVPC therapy International Symposium...Castellino SM et. al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
- Join now to see all
Lectures
- Performance of FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric hodgkin lymphoma (HL) patients.2019 ASCO Annual Meeting - 6/1/2019
- Proof-of-Paradigm of Cost-Effectiveness Analysis Within a Therapeutic Clinical Trial2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Immune Modulation in Pediatric Lymphoma2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Join now to see all
Press Mentions
 Parents of Kids with Cancer Fear GOP Budget Cuts Could Slash MedicaidApril 25th, 2025 Parents of Kids with Cancer Fear GOP Budget Cuts Could Slash MedicaidApril 25th, 2025
 Immunotherapy Extends Survival in Advanced Hodgkin LymphomaOctober 18th, 2024 Immunotherapy Extends Survival in Advanced Hodgkin LymphomaOctober 18th, 2024
 Immunotherapy Breakthrough: 92% Survival for Hodgkin Lymphoma PatientsOctober 18th, 2024 Immunotherapy Breakthrough: 92% Survival for Hodgkin Lymphoma PatientsOctober 18th, 2024
- Join now to see all
Grant Support
- Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphomaEMORY UNIVERSITY2024–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









